-+ 0.00%
-+ 0.00%
-+ 0.00%

UROGEN SUBMITS NDA FOR UGN-103, AN INVESTIGATIONAL TREATMENT OF RECURRENT LG-IR-NMIBC

Reuters·08/17/2026 12:00:02

Please log in to view news